dimethyl sulfoxide has been researched along with Glioblastoma in 10 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment of human melanoma cells with recombinant fibroblast interferon (IFN-beta) and the protein kinase C activator mezerein (MEZ) results in an irreversible loss in growth potential, suppression of tumorigenic properties and induction of terminal cell differentiation." | 3.71 | Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. ( Alexandre, D; Chada, S; Chen, Y; Christiansen, KA; Fisher, PB; Goldstein, NI; Gopalkrishnan, RV; Huang, EY; Huberman, E; Jiang, H; Kang, D; Lebedeva, IV; Leszczyniecka, M; Lin, JJ; Madireddi, MT; Mei, MX; Mhashilkar, AB; Pestka, S; Sivo, F; Su, Z; Vozhilla, N, 2001) |
| "Ruthenium compounds have been actively studied as metallodrugs for cancer therapy." | 2.46 | Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy. ( Silva, Dde O, 2010) |
| "A total of nine pseudoaneurysms treated by Onyx embolization were identified." | 1.39 | Onyx embolization for the endovascular treatment of infectious and traumatic aneurysms involving the cranial and cerebral vasculature. ( Jadhav, AP; Nogueira, RG; Pryor, JC, 2013) |
| "Glioblastoma multiforme is composed of multiple cellular compartments with different morphologic, kinetic, metabolic, vascular, and genetic properties." | 1.26 | Aggressive multimodality therapy based on a multicompartmental model of glioblastoma. ( Broadwell, RD; Ducker, TB; Kaplan, RS; Salcman, M; Samaras, GM, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Day, EK | 1 |
| Zhong, Q | 1 |
| Purow, B | 1 |
| Lazzara, MJ | 1 |
| Ricci, M | 1 |
| Ragonese, F | 1 |
| Gironi, B | 1 |
| Paolantoni, M | 1 |
| Morresi, A | 1 |
| Latterini, L | 1 |
| Fioretti, B | 1 |
| Sassi, P | 1 |
| Silva, Dde O | 1 |
| Delgado-Goñi, T | 1 |
| Martín-Sitjar, J | 1 |
| Simões, RV | 1 |
| Acosta, M | 1 |
| Lope-Piedrafita, S | 1 |
| Arús, C | 1 |
| Jadhav, AP | 1 |
| Pryor, JC | 1 |
| Nogueira, RG | 1 |
| Quayle, SN | 1 |
| Lee, JY | 1 |
| Cheung, LW | 1 |
| Ding, L | 1 |
| Wiedemeyer, R | 1 |
| Dewan, RW | 1 |
| Huang-Hobbs, E | 1 |
| Zhuang, L | 1 |
| Wilson, RK | 1 |
| Ligon, KL | 1 |
| Mills, GB | 1 |
| Cantley, LC | 1 |
| Chin, L | 1 |
| Shao, C | 1 |
| Folkard, M | 1 |
| Michael, BD | 1 |
| Prise, KM | 1 |
| Salcman, M | 2 |
| Kaplan, RS | 2 |
| Ducker, TB | 2 |
| Abdo, H | 1 |
| Montgomery, E | 1 |
| Samaras, GM | 1 |
| Broadwell, RD | 1 |
| Huang, EY | 1 |
| Madireddi, MT | 1 |
| Gopalkrishnan, RV | 1 |
| Leszczyniecka, M | 1 |
| Su, Z | 1 |
| Lebedeva, IV | 1 |
| Kang, D | 1 |
| Jiang, H | 1 |
| Lin, JJ | 1 |
| Alexandre, D | 1 |
| Chen, Y | 1 |
| Vozhilla, N | 1 |
| Mei, MX | 1 |
| Christiansen, KA | 1 |
| Sivo, F | 1 |
| Goldstein, NI | 1 |
| Mhashilkar, AB | 1 |
| Chada, S | 1 |
| Huberman, E | 1 |
| Pestka, S | 1 |
| Fisher, PB | 1 |
1 review available for dimethyl sulfoxide and Glioblastoma
| Article | Year |
|---|---|
Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Dimethyl Sulfoxide; Gliobla | 2010 |
9 other studies available for dimethyl sulfoxide and Glioblastoma
| Article | Year |
|---|---|
Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Data Science; Dimethyl Sulfoxide; DNA Repair; Drug Resis | 2021 |
Glioblastoma single-cell microRaman analysis under stress treatments.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dimethyl Sulfoxide; Glioblastoma; Glucose; Humans; Hyd | 2018 |
Dimethyl sulfoxide (DMSO) as a potential contrast agent for brain tumors.
Topics: Animals; Brain Neoplasms; Contrast Media; Dimethyl Sulfoxide; Feasibility Studies; Female; Glioblast | 2013 |
Onyx embolization for the endovascular treatment of infectious and traumatic aneurysms involving the cranial and cerebral vasculature.
Topics: Adult; Aged; Aneurysm, False; Aneurysm, Infected; Anterior Cerebral Artery; Brain Injuries; Brain Ne | 2013 |
Somatic mutations of PIK3R1 promote gliomagenesis.
Topics: Analysis of Variance; Astrocytes; Cell Survival; Cell Transformation, Neoplastic; Class Ia Phosphati | 2012 |
Bystander signaling between glioma cells and fibroblasts targeted with counted particles.
Topics: Antioxidants; Benzoates; Bystander Effect; Cell Communication; Cell Line; Cell Line, Tumor; Cocultur | 2005 |
Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma.
Topics: Adolescent; Adult; Age Factors; Aged; Brain Neoplasms; Carmustine; Dimethyl Sulfoxide; Doxorubicin; | 1982 |
Aggressive multimodality therapy based on a multicompartmental model of glioblastoma.
Topics: Brain Neoplasms; Carmustine; Dimethyl Sulfoxide; Drug Therapy, Combination; Glioblastoma; Hot Temper | 1982 |
Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Topics: Antigens, Neoplasm; Apoptosis; Base Sequence; Carcinoma; Cell Differentiation; Cell Division; Chromo | 2001 |